Skye Bioscience Inc (SKYE)

[frozenspokes]

Reposting this article. The IP they own and continue to build is spectacular. The waiting is a grind, but will eventually pay out...

"The two drug candidate formulations include a synthetic prodrug of tetrahydrocannabinol, commonly known as THC, the main psychoactive compound associated with marijuana, and a synthetic analog of cannabidiol another compound that is attracting widespread attention as a potential treatment for a variety of medical conditions. Both drug candidates are derivatives of the natural THC and CBD found in the cannabis plant.'

"The second drug candidate, the THC prodrug, is an inactive form of THC that becomes activated when absorbed into the body. Along with Emerald Bioscience, Ole Miss and ELI researchers developed a THC prodrug to treat glaucoma that can be absorbed through the tissues in the eye after a simple eyedrop application.
“Getting to this pivotal point took almost 10 years,” said Soumyajit Majumdar, professor of pharmaceutics and drug delivery and leader of the THC prodrug research team. “The Ole Miss and ELI research teams developed many iterations of the THC prodrug, balancing the characteristics of the compounds to come up with a molecule and an ophthalmic formulation that has the optimal characteristics to treat glaucoma effectively.”"


https://news.olemiss.edu/um-partners-emerald-bioscience-license-cannabis-derived-drugs/